Lead Plaintiff Deadline: March 08, 2021
Please Upload related files below
Fill in below.
Looking for more?
(i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
In order to be included in the lawsuit, you must have incurred a loss on shares of Tricida purchased during the class period listed above.
If you suffered a loss in Tricida during the relevant time frame, you have until March 08, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.